top of page

Middle East CF Association Log

Nutritional Care in Cystic Fibrosis Across the Arab World: Regional Heterogeneity, Current Evidence, and Future Directions

11 minutes ago

1 min read

Ala K. Shaikhkhalil 1,*, Mutasim Abu-Hasan 2, Serena Sharpe 3 and Fadi Asfour 4,5

Comments

Featured Posts

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

A case for improved carrier screening

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

The search for molecular glue in targeted disease control

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p

Recent Posts

Nutritional Care in Cystic Fibrosis Across the Arab World: Regional Heterogeneity, Current Evidence, and Future Directions

CF therapy linked to better lung function, fewer flare-ups in children

Adults with CF want more genetic counseling, survey finds

International CF Training Network and MECFA Diagnostics Program Expand to Pakistan in Partnership with Indus Hospital and Health Network

Two Stickers and a Phone Camera Matched the Lab Test for Cystic Fibrosis, at About a Dollar a Test

FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug Development

Cystic fibrosis signs in newborns may not predict poorer long-term outcomes

'100M Healthy Lives' Initiative: 792K newborns screened for genetic diseases

Phase 2a trial testing mRNA therapy in cystic fibrosis fully enrolled

CFF funds cell-based strategy to help rebuild damaged CF airways

Archive

Search By Tags

bottom of page